The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA is working on a plan to allow pharmaceutical companies to distribute information to doctors about a drug’s off label usage. The information would be stricly monitored and would include articles from scholarly medical journals. However, if the findings from the medical journal are disputed, the contrary evidence would have to be included in the dissemination to doctors. Off label prescribing of drugs is common and is not illegal, drug companies are prohibited from marketing drugs for purposes that are not specifically approved by the FDA.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest